BICO Group
46.44 SEK -17.51%3 investors are following this company
BICO Group is active in medical technology. The company specializes in bio convergence and provides technology, products, and services for biology. With a focus on the application areas bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets technology that enables researchers to grow cells in 3D environments, conduct drug screening, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BICO
Daily low / high price
45.68 / 56.35
SEK
Market cap
3.28B SEK
Turnover
60.84M SEK
Volume
1.2M
Latest videos
Financial calendar
Interim report
2024-11-13
Annual report
2025-02-19
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Erik Gatenholm | 13.6 % | 20.5 % |
Sartorius AG | 10.1 % | 8.5 % |
Handelsbanken Fonder | 9.6 % | 8.1 % |
Hector Daniel Martinez Avila | 9.0 % | 13.6 % |
Fjärde AP-Fonden | 6.3 % | 5.3 % |
Tredje AP-Fonden | 3.9 % | 3.3 % |
Avanza Pension | 1.5 % | 1.3 % |
Claes Dinkelspiel | 1.5 % | 1.3 % |
ARK Investment Management LLC | 1.4 % | 1.2 % |
Carl Bennet | 1.4 % | 1.2 % |
ShowingAll content types
BICO’ Capital Markets Day 2024: Launch of BICO’s Updated strategy, BICO 2.0
BICO, Capital Markets Day, 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools